Impact of cyclosporin a pharmacokinetics on the presence of side effects in pediatric renal transplantation

Journal of the American Society of Nephrology

Volumn 11, Issue 2, 2000, Pages 343-349

  David Neto, Elias ^a,b   Lemos, Francine Brambate Carvalhinho ^a   Furusawa, Erika Arai ^a   Schwartzman, Benita Soares ^a   Cavalcante, Juliana Soares ^a   Yagyu, Elisa Midori ^a   Romano, Paschoalina ^a   Ianhez, Luis Estevan ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b 263   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; FEMALE; GINGIVA HYPERPLASIA; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL; TREMOR;

EID: 0033959965     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Shield CF III, McGrath MM, Goss TF: Assessment of health-related quality of life in kidney transplant patients receiving tacrolimus (FK506)-based versus cyclosporine-based immunosuppression: FK506 Kidney Transplant Study Group. Transplantation 64: 1738-1743, 1997
2. Barone G, Chang CT, Choc MG Jr, Klein JB, Marsh CL, Meligeni JA, Min DI, Pescovitz MD, Pollak R, Pruett TL, Stinson JB, Thompson JS, Vasquez, E, Waid T, Wombolt DG, Wong RL: The pharmacokinetics of a microemulsion formulation of cyclosporine in primary renal allograft recipients: The Neoral Study Group. Transplantation 61: 875-880, 1996
3. Cooney GF, Lum BL, Meligeni JA, Dunn SP: Pharmacokinetics of a microemulsion formulation of cyclosporine in pediatric liver transplant recipients. Transplant Proc 28: 2270-2272, 1996
4. Cooney GF, Habucky K, Hoppu K: Cyclosporin pharmacokinetics in paediatric transplant recipients. Clin Pharmacokinet 32: 481-495, 1997
5. Erkko P, Granlund H, Nuutinen M, Reitamo S: Comparison of cyclosporin A pharmacokinetics of a new microemulsion formulation and standard oral preparation in patients with psoriasis. Br J Dermatol 136: 82-88, 1997
6. Fu LW, Yang LY, Chen WP, Lin CY: Cyclosporin pharmacokinetics following administration of capsules and Neoral in paediatric patients with lupus nephritis. Br J Clin Pharmacol 44: 125-127, 1997
7. Krmar RT, Wuhl E, Ding R, Aulmann M, Scharer K: Pharmacokinetics of a new microemulsion formulation of cyclosporin A (Neoral) in young patients after renal transplantation. Transplant Int 9: 476-480, 1996
8. Bokenkamp A, Bohnhorst B, Beier C, Albers N, Offner G, Brodehl J: Nifedipine aggravates cyclosporine A-induced gingival hyperplasia. Pediatr Nephrol 8: 181-185, 1994
9. Meir-Kriesche HU, Bonilla-Felix MA, Swinford R, Ferris M, Kahan BD, Portman RJ: An early concentration time point-based limited sampling strategy to predict the area under the curve (AUC) in pediatric renal transplant recipients (PRTR) on q12 hour Neoral dosing [Abstract]. J Am Soc Nephrol 9: 686A, 1998
10. Dostal C, Tesar V, Rychlik I, Zabka J, Vencovsky J, Bartunkova J, Stejskalova A, Tegzova D: Effect of 1 year cyclosporine A treatment on the activity and renal involvement of systemic lupus erythematosus: A pilot study. Lupus 7: 29-36, 1998
11. Burrows L, Knight R, Genyk Y, Schwartz B, Moran V, Anand R: Conversion to tacrolimus to ameliorate cyclosporine toxicity in kidney recipients. Transplant Proc 30: 2030-2032, 1998
12. Mayer AD, Dmitrewski J, Squifflet JP, Besse T, Grabensee B, Klein B, Eigler FW, Heemann U, Pichlmayr R, Behrend M, Vanrenterghem Y, Donck J, van Hooff J, Christiaans M, Morales JM, Andres A, Johnson RW, Short C, Buchholz B, Rehmert N, Land W, Schleibner S, Forsythe JL, Talbot D, Pohanka E: Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: A report of the European Tacrolimus Multicenter Renal Study Group. Transplantation 64: 436-443, 1997
13. Sullu Y, Oge I, Erkan D, Ariturk N, Mohajeri F: Cyclosporin-A therapy in severe uveitis of Behcet's disease. Acta Ophthalmol Scand 76: 96-99, 1998
14. Williams R, Neuhaus P, Bismuth H, McMaster P, Pichlmayr R, Calne R, Otto G, Groth C: Two-year data from the European multicentre tacrolimus (FK506) liver study. Transplant Int 9: S144-S150, 1996
15. Palomo S, Noujaim J, Helms L, Halloran PF: Differences among organs in calcineurin inhibition by cyclosporin may explain toxicity in vivo [Abstract]. Transplantation 67: S62, 1999
16. Perico N, Ruggenenti P, Gaspari F, Mosconi L, Benigni A, Amuchastegui CS, Gasparini F, Remuzzi G: Daily renal hypoperfusion induced by cyclosporine in patients with renal transplantation. Transplantation 54: 56-60, 1992
17. Kahan BD, Welsh M, Rutzky LP: Challenges in cyclosporine therapy: The role of therapeutic monitoring by area under the curve monitoring. Ther Drug Monit 17: 621-624, 1995
18. Pai SY, Fruman DA, Leong T, Neuberg D, Rosano TG, McGarigle C, Antin JH, Bierer BE: Inhibition of calcineurin phosphatase activity in adult bone marrow transplant patients treated with cyclosporine A. Blood 84: 3974-3979, 1994
19. Batiuk TD, Pazderka F, Halloran PF: Calcineurin activity is only partially inhibited in leukocytes of cyclosporine-treated patients. Transplantation 59: 1400-1404, 1995
20. Batiuk TD, Pazderka F, Enns J, DeCastro L, Halloran PF: Cyclosporine inhibition of calcineurin activity in human leukocytes in vivo is rapidly reversible. J Clin Invest 96: 1254-1260, 1995
21. Quien RM, Kaiser BA, Dunn SP, Kulinsky A, Polinsky M, Baluarte HJ, Batiuk TD, Halloran PF: Calcineurin activity in children with renal transplants receiving cyclosporine. Transplantation 64: 1486-1489, 1997
22. de Mattos AM, Norman DJ, Olyaei A, Barry JM, Bennett WM: The kinetics of calcineurin inhibition on stable renal transplant recipients during conversion from Sandimmun to Neoral cyclosporin A [Abstract]. J Am Soc Nephrol 9: A3424, 1998
23. Keown P, Kahan BD, Johnston A, Levy G, Dunn SP, Cittero F, Grino JM, Hoyer PF, Wolf P, Halloran PF: Optimization of cyclosporine therapy with new therapeutic drug monitoring strategies: Report from the International Neoral TDM Advisory Consensus Meeting (Vancouver, November 1997). Transplant Proc 30: 1645-1649, 1998
24. Nares S, Ng MC, Dill RE, Park B, Cutler CW, Iacopino AM: Cyclosporine A upregulates platelet-derived growth factor B chain in hyperplastic human gingiva. J Periodontol 67: 271-278, 1996
25. Somacarrera ML, Lucas M, Acero J: Reversion of gingival hyperplasia in a heart transplant patient upon interruption of cyclosporine therapy. Spec Care Dentist 16: 18-21, 1996
26. Ruggenenti P, Perico N, Mosconi E, Gaspari F, Benigni A, Amuchastegui CS, Bruzzi I, Remuzzi G: Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion. Kidney Int 43: 706-711, 1993
27. Willershausen-Zonnchen B, Lemmen C, Zonnchen B, Hamm G, Schumacher U: Influence of nifedipine on the metabolism of gingival fibroblasts. Biol Chem Hoppe Seyler 375: 299-303, 1994
28. Pascual-Castroviejo I, Pascual Pascual SI: Nicardipine-induced gingival hyperplasia [Spanish]. Neurologia 12: 37-39, 1997